Brady Corp
BRC NYSE Miscellaneous Manufacturing Industries Financials FY2017βFY2026
Last close Β· Oct 23, 2026
$81.59
1.3%What Brady Corp does
No business description yet.
- Legal name
- BRADY CORP
- Fiscal year ends
- July 31, 2026
- Latest annual report
- 10-K Β· Sep 3, 2026
- Accession Β· CIK
- 0000746598-26-000044
0000746598
Revenue and margins
Brady Corp had $1.7B of revenue in fiscal 2026, up 9.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $193M in fiscal 2026, 11.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Brady Corp returned $88.3M to shareholders in fiscal 2026, 46% of free cash flow. The diluted share count fell 0.7%.
Balance sheet
Cash, debt and the ratios that show how comfortably Brady Corp can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $114M | $152M | $250M | $174M | $187M |
| Debt incl. finance leases | β | β | $90.9M | $99.8M | $15.0M |
| Net debt / EBITDA | β | β | β0.6x | β0.3x | β0.6x |
| Debt / equity | β | β | 0.1x | 0.1x | 0.0x |
| Interest coverage | 151.3x | 63.6x | 77.9x | 49.9x | 27.2x |
| Current ratio | 2.0x | 2.0x | 2.3x | 1.9x | 1.9x |
| Quick ratio | 1.2x | 1.3x | 1.7x | 1.3x | 1.3x |
| Total assets | $1.4B | $1.4B | $1.5B | $1.7B | $1.9B |
| Total liabilities | $456M | $398M | $449M | $542M | $494M |
| Shareholders' equity | $911M | $991M | $1.1B | $1.2B | $1.4B |
| Net debt (β = net cash) | β | β | β$159M | β$74.6M | β$172M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 6 / 9 | 5 / 9 | 6 / 9 | 5 / 8 | 6 / 8 | 8 / 8 | 7 / 8 | 4 / 9 | 9 / 9 |
| Accruals ratio | β4.6% | β4.9% | β2.8% | β2.5% | β6.0% | 2.3% | β2.5% | β4.0% | 0.5% | β2.2% |
| Altman Z'' | 5.89 | 6.83 | 7.02 | 7.51 | 6.11 | 6.34 | 7.36 | 7.55 | 6.81 | 7.62 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.1B | $1.2B | $1.2B | $1.1B | $1.1B | $1.3B | $1.3B | $1.3B | $1.5B | $1.7B |
| Gross profit | $558M | $588M | $579M | $529M | $561M | $632M | $657M | $688M | $761M | $860M |
| Research and development | $39.6M | $45.3M | $45.2M | $40.7M | $44.6M | $58.5M | $61.4M | $67.7M | $79.9M | $94.0M |
| Operating income | $131M | $153M | $162M | $138M | $167M | $193M | $225M | $243M | $237M | $263M |
| Interest expense | $5.5M | $3.2M | $2.8M | $2.2M | $0.4M | $1.3M | $3.5M | $3.1M | $4.7M | $9.7M |
| Pretax income | $127M | $152M | $165M | $141M | $171M | $192M | $226M | $248M | $237M | $259M |
| Income tax | $31.0M | $61.0M | $33.4M | $28.3M | $35.6M | $42.0M | $50.8M | $50.6M | $47.8M | $54.0M |
| Net income | $95.6M | $91.1M | $131M | $112M | $130M | $150M | $175M | $197M | $189M | $205M |
| Diluted shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $144M | $143M | $162M | $141M | $206M | $118M | $209M | $255M | $181M | $244M |
| Capital expenditure | $15.2M | $21.8M | $32.8M | $27.3M | $27.2M | $43.1M | $19.2M | $79.9M | $27.6M | $51.5M |
| Free cash flow | $129M | $121M | $129M | $114M | $178M | $75.3M | $190M | $175M | $154M | $193M |
| Depreciation and amortization | $27.3M | $25.4M | $23.8M | $23.4M | $25.5M | $34.2M | $32.4M | $29.9M | $40.6M | $44.9M |
| Stock-based compensation | $9.5M | $10.0M | $12.1M | $8.8M | $10.1M | $10.5M | $7.5M | $7.4M | $11.9M | $22.9M |
| Acquisitions | β | β | $0.0M | $0.0M | $244M | $0.0M | $0.0M | $0.0M | $145M | $17.4M |
| Share buybacks | $0.0M | $1.5M | $3.2M | $64.5M | $3.6M | $109M | $75.0M | $72.2M | $50.8M | $42.2M |
| Dividends paid | $41.9M | $42.9M | $44.7M | $45.8M | $45.7M | $45.9M | $45.4M | $45.1M | $45.5M | $46.1M |
| Dividends and buybacks | $41.9M | $44.3M | $47.9M | $110M | $49.3M | $155M | $120M | $117M | $96.4M | $88.3M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $134M | $181M | $279M | $218M | $147M | $114M | $152M | $250M | $174M | $187M |
| Total debt | $105M | $52.6M | $50.2M | $0.0M | β | β | β | $90.9M | $99.8M | $15.0M |
| Current assets | $408M | $471M | $573M | $509M | $465M | $498M | $525M | $600M | $622M | $689M |
| Current liabilities | $187M | $191M | $242M | $186M | $258M | $255M | $258M | $265M | $330M | $356M |
| Inventory | $107M | $113M | $120M | $136M | $136M | $190M | $177M | $153M | $201M | $225M |
| Property and equipment, net | $98.1M | $97.9M | $110M | $115M | $122M | $140M | $142M | $196M | $226M | $254M |
| Goodwill | $438M | $420M | $411M | $416M | $614M | $587M | $593M | $590M | $677M | $686M |
| Intangible assets | $53.1M | $42.6M | $36.1M | $22.3M | $92.3M | $74.0M | $62.1M | $51.8M | $105M | $97.8M |
| Total assets | $1.1B | $1.1B | $1.2B | $1.1B | $1.4B | $1.4B | $1.4B | $1.5B | $1.7B | $1.9B |
| Total liabilities | $350M | $305M | $307M | $279M | $415M | $456M | $398M | $449M | $542M | $494M |
| Shareholders' equity | $700M | $700M | $700M | $752M | $963M | $911M | $991M | $1.1B | $1.2B | $1.4B |
| Margins | ||||||||||
| Gross margin | 50.1% | 50.1% | 49.9% | 48.9% | 49.0% | 48.5% | 49.4% | 51.3% | 50.3% | 51.7% |
| Operating margin | 11.8% | 13.0% | 14.0% | 12.8% | 14.6% | 14.8% | 16.9% | 18.1% | 15.6% | 15.9% |
| EBITDA margin | 14.2% | 15.2% | 16.0% | 14.9% | 16.8% | 17.4% | 19.3% | 20.4% | 18.3% | 18.6% |
| Net margin | 8.6% | 7.8% | 11.3% | 10.4% | 11.3% | 11.5% | 13.1% | 14.7% | 12.5% | 12.4% |
| FCF margin | 11.6% | 10.3% | 11.1% | 10.5% | 15.6% | 5.8% | 14.3% | 13.1% | 10.1% | 11.6% |
| Returns | ||||||||||
| Return on capital | 14.8% | 17.4% | 27.5% | 20.6% | β | β | β | 21.3% | 16.9% | 17.6% |
| Return on capital employed | 15.2% | 17.6% | 17.7% | 14.4% | 14.9% | 17.4% | 19.9% | 19.5% | 16.9% | 17.6% |
| Return on equity | 13.7% | 13.0% | 18.7% | 15.5% | 15.1% | 16.0% | 18.4% | 19.2% | 16.8% | 16.1% |
| Return on assets | 9.1% | 8.6% | 11.9% | 9.8% | 10.3% | 10.9% | 12.7% | 13.6% | 11.6% | 11.5% |
| Return on tangible equity | 45.7% | 38.3% | 51.9% | 35.8% | 50.5% | 59.9% | 52.0% | 46.4% | 46.2% | 35.8% |
| Growth | ||||||||||
| Revenue growth | β | 5.4% | β1.1% | β6.8% | 5.9% | 13.7% | 2.3% | 0.7% | 12.8% | 9.8% |
| Net income growth | β | β4.8% | 44.1% | β14.4% | 15.4% | 15.7% | 16.6% | 12.8% | β4.0% | 8.5% |
| FCF growth | β | β5.9% | 6.7% | β12.1% | 57.0% | β57.8% | 152.2% | β7.8% | β12.3% | 25.4% |
| Share count change | β | 1.1% | 1.5% | β0.2% | β1.5% | β1.4% | β3.5% | β2.8% | β0.8% | β0.7% |
| Financial health | ||||||||||
| Net debt / EBITDA | β0.2x | β0.7x | β1.2x | β1.3x | β | β | β | β0.6x | β0.3x | β0.6x |
| Debt / equity | 0.1x | 0.1x | 0.1x | 0.0x | β | β | β | 0.1x | 0.1x | 0.0x |
| Interest coverage | 23.8x | 48.2x | 57.4x | 63.7x | 382.4x | 151.3x | 63.6x | 77.9x | 49.9x | 27.2x |
| Current ratio | 2.2x | 2.5x | 2.4x | 2.7x | 1.8x | 2.0x | 2.0x | 2.3x | 1.9x | 1.9x |
| Quick ratio | 1.6x | 1.9x | 1.9x | 2.0x | 1.3x | 1.2x | 1.3x | 1.7x | 1.3x | 1.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.4% | 1.9% | 2.8% | 2.5% | 2.4% | 3.3% | 1.4% | 6.0% | 1.8% | 3.1% |
| Stock comp / revenue | 0.9% | 0.9% | 1.0% | 0.8% | 0.9% | 0.8% | 0.6% | 0.5% | 0.8% | 1.4% |
| Payouts / FCF | 32.5% | 36.6% | 37.0% | 97.0% | 27.6% | 206.0% | 63.4% | 67.0% | 62.7% | 45.9% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 6.0 | 5.0 | 6.0 | 5.0 | 6.0 | 8.0 | 7.0 | 4.0 | 9.0 |
| Altman Z'' | 5.9 | 6.8 | 7.0 | 7.5 | 6.1 | 6.3 | 7.4 | 7.5 | 6.8 | 7.6 |
| Accruals ratio | β4.6% | β4.9% | β2.8% | β2.5% | β6.0% | 2.3% | β2.5% | β4.0% | 0.5% | β2.2% |
Source: SEC EDGAR XBRL filings (CIK 0000746598). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.